Special Issue: "Anti-inflammatory Effects of Glucagon-like Peptide-1"

Int J Mol Sci. 2024 Feb 7;25(4):1997. doi: 10.3390/ijms25041997.

Authors

Alessandra Puddu¹, Davide Maggi¹

Affiliation

¹ Department of Internal Medicine and Medical Specialties, University of Genoa, 16132 Genoa, Italy.

Abstract

From the failure of gut extracts in diabetic patients' therapy to the effective action in cardiovascular outcomes [...].

Publication types

Editorial

MeSH terms

Anti-Inflammatory Agents / pharmacology
Anti-Inflammatory Agents / therapeutic use
Cardiovascular System*
Diabetes Mellitus, Type 2* / drug therapy
Glucagon-Like Peptide 1 / pharmacology
Glucagon-Like Peptide 1 / therapeutic use
Glucagon-Like Peptide-1 Receptor
Heart
Humans
Hypoglycemic Agents / pharmacology

Substances

Glucagon-Like Peptide 1
Anti-Inflammatory Agents
Glucagon-Like Peptide-1 Receptor
Hypoglycemic Agents